Out-Licence Agreement Sample Contracts

EX-10.11 17 d621839dex1011.htm EX-10.11 ***Text Omitted and Filed Separately with the Securities and Exchange Commission. Confidential Treatment Requested Under 17 C.F.R. Sections 200.80(b)(4) and 230.406. OUT-LICENCE AGREEMENT by and between...

Out-Licence Agreement • May 5th, 2020 • England

• Contract Type
  Out-Licence Agreement
• Filed
  May 5th, 2020
• Jurisdiction
  England

NOW, THEREFORE, in consideration of the mutual covenants contained in this Agreement, and other good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, the Parties, intending to be legally bound, agree as follows:

Contract

Out-Licence Agreement • April 11th, 2012 • Navidea Biopharmaceuticals, Inc. • In vitro & in vivo diagnostic substances • England and Wales

• Contract Type
  Out-Licence Agreement
• Filed
  April 11th, 2012
• Company
  Navidea Biopharmaceuticals, Inc.
• Industry
  In vitro & in vivo diagnostic substances
• Jurisdiction
  England and Wales

Confidential Treatment – Asterisked material has been omitted and filed separately with the Securities and Exchange Commission pursuant to a request for confidential treatment.